Patient’s background characteristics
Factor | N |
Total | 59 |
Age | |
55–59 | 9 |
60–69 | 33 |
70–79 | 17 |
T | |
2 | 57 |
3 | 2 |
N | |
0 | 43 |
1 | 16 |
Clinical stage | |
IIA | 43 |
IIB | 14 |
IIIA | 2 |
ER | |
+ | 59 |
− | 0 |
PgR | |
+ | 55 |
− | 4 |
HER2 | |
+ | 0 |
− | 59 |
Adjuvant chemotherapy | |
+ | 18 |
− | 41 |
ER, oestrogen receptor;HER2, human epidermal growth factor receptor 2; PgR, progesterone receptor.